Skip to main content

         This documentation site is for previous versions. Visit our new documentation site for current releases.      

Regulatory details in Enrich stage and GKYC sub-case

Updated on September 28, 2022

In the ‘Regulatory details’ step within the Enrich stage, the user (who, depending on the financial institution’s Target Operating Model, can be for example the back-office department responsible for performing due diligence on the customer, or the Relationship Manager or a Mid-office employee) must answer the question – when the second scenario applies (see section ‘Triggers’) – on whether in relation to the OTC product booked outside of the USA the customer has a US nexus that requires obtaining a Cross-Border Representation Letter.

The financial institution can configure this field in the ‘Regulatory details’ step according to their procedures.

In its out-of-the-box behaviour, the input entered within the ‘Regulatory details’ step does not pre-populate the relevant DFA item in the Global AML questionnaire of the customer (i.e. GKYC sub-case) within the Due Diligence stage, but that can be easily configured.

The answer “Yes” to the following DFA item in the GKYC sub-case of the customer will determine whether the DFA questionnaire will be displayed.

Have a question? Get answers now.

Visit the Support Center to ask questions, engage in discussions, share ideas, and help others.

Did you find this content helpful?

Want to help us improve this content?

We'd prefer it if you saw us at our best. is not optimized for Internet Explorer. For the optimal experience, please use:

Close Deprecation Notice
Contact us